Original scientific paper
https://doi.org/10.1080/1331677X.2017.1311223
IPR scenario and factors for promoting IPR culture: a post-TRIPS period analysis of selected pharmaceutical firms in North India
Ravi Kiran
Abstract
Different shades of World Trade Organization (WTO) agreement on
trade-related intellectual property rights (TRIPS) are reflected in
the Indian pharmaceutical industry, but small and medium-scale
pharmaceutical firms are slowly increasing their product innovation,
process innovation and research and development (R&D) intensity.
Analysis of variance results highlight a significant difference in
performance of sole proprietorship/partnership, private limited and
public limited firms vis-à-vis product innovation, process innovation,
increased range of goods and services, R&D intensity, new technology
adoption and adaptation. Factor analysis results indicated that
developing intellectual property rights (IPR), technological measures
and marketing practices explained 80.256% of variation. Policy
initiative factor is dominating and SMEs are still relying heavily on
support from government.
Keywords
Trade-related intellectual property rights (TRIPS); intellectual property rights (IPRs); R&D intensity; small and medium enterprises (SMEs); pharmaceutical industry
Hrčak ID:
182575
URI
Publication date:
1.12.2017.
Visits: 894 *